Cancer-inhibiting compound found under seaAugust 8th, 2008 - 10:54 am ICT by IANS
Washington, Aug 8 (IANS) A marine compound discovered off the coast of Key Largo in Florida inhibits cancer cell growth in lab tests and is likely to prompt the development of effective new drugs. The University of Florida patented compound, largazole, is derived from cyanobacteria that grow on coral reefs. It is being described as one of the most promising finds since the college’s marine lab was established three years ago.
The molecule’s natural chemical structure and ability to inhibit cancer cell growth were first described in the Journal of American Chemical Society in February and the lab synthesis and description of molecular basis for its anticancer activity appeared on July 2.
“It’s exciting because we’ve found a compound in nature that may one day surpass a currently marketed drug or could become the structural template for rationally designed drugs with improved selectivity,” said Hendrik Luesch, assistant professor in UF’s department of medicinal chemistry and the study’s principal investigator.
Largazole, discovered and named by Luesch for its Florida location and structural features, seeks out a family of enzymes called histone deacetylase, or HDAC. Overactivity of certain HDACs has been associated with several cancers such as prostate and colon tumours, and inhibiting HDACs can activate tumour-suppressor genes that have been silenced in these cancers.
Although scientists have been probing the depths of the ocean for marine products since the early 1960s, many pharmaceutical companies lost interest before researchers could deliver useful compounds because natural products were considered too costly and time-consuming to research and develop.
Many common medications, from pain relievers to cholesterol-reducing statins, stem from natural products that grow on the earth, but there is literally an ocean of compounds yet to be discovered in our seas.
Only 14 natural marine products developed are in clinical trials today, Luesch said, and one drug recently approved in Europe is the first-ever marine-derived anticancer agent.
“Marine study is in its infancy,” said William Fenical, professor of oceanography and pharmaceutical sciences at the University of California, San Diego. “The ocean is a genetically distinct environment and the single, most diverse source of new molecules to be discovered.”
HDACs are already targeted by a drug approved for cutaneous T-cell lymphoma manufactured by the global pharmaceutical company Merck & Co. Inc. However, UF’s compound does not inhibit all HDACs equally, meaning a largazole-based drug might result in improved therapies and fewer side effects, Luesch said.
Luesch said that within the next few months he plans to study whether largazole reduces or prevents tumour growth in mice. Luesch has several other anti-tumour natural products from Atlantic and Pacific cyanobacteria in the pipeline.
These results were presented Thursday at an international natural products scientific meeting in Athens.
- Mother Nature's new gift to prevent and treat bone diseases - Feb 03, 2011
- Cancer-inhibiting compound found under the sea - Aug 08, 2008
- Chemists synthesise promising anti-cancer product - Aug 21, 2008
- Promising anti-cancer marine algae extract synthesized - Aug 21, 2008
- Scientists identify four anti-cancer compounds - Nov 30, 2011
- Potent anticancer drug isolated from weed - Jul 10, 2012
- Overabundance of protein promotes growth of breast cancer stem cells - Feb 16, 2011
- New discovery may help explain how cancer cells spread - Jun 01, 2010
- Synthetic compound may lead to drugs to fight pancreatic, lung cancer - Mar 10, 2011
- Beehive extract may arrest prostate cancer - May 06, 2012
- Arsenic could be a potential cancer treatment - Jul 13, 2010
- Arthritis drug could help treat skin cancer - Mar 24, 2011
- Nicotine linked to breast cancer for first time - Aug 24, 2010
- Carrots can help prevent breast cancer - Apr 06, 2011
- Plant stem cells pave way for low-cost cancer drug - Oct 26, 2010
Tags: american chemical society, anticancer activity, cancer cell growth, chemical structure, colon tumours, coral reefs, cyanobacteria, florida location, journal of american chemical society, key largo, lab tests, medicinal chemistry, molecular basis, new drugs, overactivity, pain relievers, principal investigator, selectivity, tumour suppressor genes, university of florida